Tue, Oct 29, 2024

12:45 PM – 2 PM EDT (GMT-4)

Add to Calendar

Private Location (sign in to display)

350
Registered

Registration

Details

The Silfen Leadership Series is an initiative wherein world-renowned leaders come to campus to speak to students. It is funded by an endowment set up by David ’68 and Lyn Silfen. Each year, a board of six to eight students is selected, with whom we work to run each Silfen session.

As a student-run venture, in conjunction with the Dean's Office and the Office of Development and Alumni Relations, the Series aims to enhance the shared access to intellectual capital between students and the leaders who drive organizations, societies, and markets forward.

This session will be featuring Zoetis CEO, Kristin Peck '99.

Kristin Peck is Chief Executive Officer of Zoetis, the world’s leading animal health company and a member of the Fortune 500. Ms. Peck is also a member of the Zoetis Board of Directors.

Prior to becoming CEO in 2020, Ms. Peck was executive vice president and group president, U.S. Operations, Business Development and Strategy at Zoetis. Ms. Peck helped usher Zoetis through its Initial Public Offering in 2013 and has been a driving force of change in many roles at the company, including Global Manufacturing and Supply, Global Poultry, Global Diagnostics, Corporate Development, and New Product Marketing and Global Market Research. Recognized for her transformative leadership and Zoetis’ strong performance in challenging times, Ms. Peck was named to the CNBC 2024 Changemakers list; selected by Barron’s as one of the top CEOs in 2022, and by Fortune as a 2020 Businessperson of the Year.

Before joining Zoetis, Ms. Peck served as executive vice president, Worldwide Business Development and Innovation at Pfizer Inc., and as a member of Pfizer's Executive Leadership Team. In that role, she was responsible for the evaluation of strategic alternatives for Pfizer's Animal Health and Nutrition businesses – paving the way for a public animal health company and attractive investment opportunity.

Prior to joining Pfizer, Ms. Peck held roles at The Boston Consulting Group (BCG) as well as in private equity and real estate finance at The Prudential Realty Group, The O'Connor Group and J.P. Morgan.
Ms. Peck serves on the boards of BlackRock, Mayo Clinic, and Columbia Business School, and is a member of the Business Roundtable. She is also a Board member of Catalyst, a global non-profit that helps companies accelerate women into leadership.

Ms. Peck holds a bachelor's degree from Georgetown University and an MBA from Columbia Business School.
Dress Business Casual
Food Provided (Lunch will be served on a first come, first serve basis. )

Speakers

Kristin Peck's profile photo

Kristin Peck

CEO

Zoetis

https://www.linkedin.com/in/kristin-peck

Kristin Peck is Chief Executive Officer of Zoetis, the world’s leading animal health company and a member of the Fortune 500. Ms. Peck is also a member of the Zoetis Board of Directors.



Prior to becoming CEO in 2020, Ms. Peck was executive vice president and group president, U.S. Operations, Business Development and Strategy at Zoetis. Ms. Peck helped usher Zoetis through its Initial Public Offering in 2013 and has been a driving force of change in many roles at the company, including Global Manufacturing and Supply, Global Poultry, Global Diagnostics, Corporate Development, and New Product Marketing and Global Market Research. Recognized for her transformative leadership and Zoetis’ strong performance in challenging times, Ms. Peck was named to the CNBC 2024 Changemakers list; selected by Barron’s as one of the top CEOs in 2022, and by Fortune as a 2020 Businessperson of the Year.

Before joining Zoetis, Ms. Peck served as executive vice president, Worldwide Business Development and Innovation at Pfizer Inc., and as a member of Pfizer's Executive Leadership Team. In that role, she was responsible for the evaluation of strategic alternatives for Pfizer's Animal Health and Nutrition businesses – paving the way for a public animal health company and attractive investment opportunity.



Prior to joining Pfizer, Ms. Peck held roles at The Boston Consulting Group (BCG) as well as in private equity and real estate finance at The Prudential Realty Group, The O'Connor Group and J.P. Morgan.



Ms. Peck serves on the boards of BlackRock, Mayo Clinic, and Columbia Business School, and is a member of the Business Roundtable. She is also a Board member of Catalyst, a global non-profit that helps companies accelerate women into leadership.



Ms. Peck holds a bachelor's degree from Georgetown University and an MBA from Columbia Business School.

Hosted By

Silfen Leadership Series | Website | View More Events
Co-hosted with: Healthcare and Pharmaceutical Management Program, Phillips Pathway for Inclusive Leadership

Contact the organizers